pubmed.ncbi.nlm.nih.gov/388...
A 2024 study on WORLDWIDE prevalence of RLS shows there are
356.07 million people with RLS.
(7.12% of the world population).
That is a LOT of people and LOADSA money for the pharmaceutical companies making dopamine agonists.
No wonder they don't want the medical profession to learn how to treat it properly and stop prescribing dopamine agonists.